Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biomaterials.
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Biomaterials.
Abstract Submission Deadline
April 20, 2022
Early Bird Registration
February 15, 2022
May 16-18, 2022
or reload the browser
or reload the browser
or reload the browser
or reload the browser
CEO-NanoRegMed Ltd UK
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He supervised 121 PhD students, all successfully completed. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for medical and other industrial applications and synthetic graphene-based nanocomposite materials for surgical and medical devices application. He is currently working on the development of facial organs, heart valves and tendons.
University of Pennsylvania USA
Dr. Steier serves currently as Clinical Professor at the University of Pennsylvania – Dental School in the Department of Preventive and Restorative Sciences, Robert Schattner Center, University of Pennsylvania, School of Dental Medicine and holds visiting appointments at: a. Saveetha Dental College; b. Federal University of Rio Grande del Sul. In the US, he served as Scientific Advisory Board Member for the Journal of Endodontics, and as Editor, Editor-in-Chief and Reviewer of a multitude of peer-reviewed journals, including the Journal of Dental Education. He has also been a long-standing member of the American Academy of Periodontology and the American Association of Endodontists. Dr. Steier is an internationally recognized lecturer known for his hands-on teaching style, innovative spirit, and both his breadth and depth of knowledge. He has co-developed several breakthrough technologies in diagnosis, treatment guidance and disinfection. His award-winning work and numerous publications have been distinguished by authorities in the field around the globe and he continues to make outstanding contributions in both practice and scholarship that have received widespread acclaim by clinicians and scientists across the world.
Co-founder & CSO Keystone Nano, Inc, USA
James H. Adair is a Professor in Materials Science and Engineering, Bioengineering and Pharmacology at The Pennsylvania State University. His research and teaching interests include biological-nanoscale composite particulates for nanomedical applications, colloid and interfacial chemistry, material chemistry, nanoparticle characterization, and ceramic and metal particulate processing. Dr. Adair received his A.A. degree in Chemistry from Palm Beach Junior College (1972), and B.S. in Chemistry (1975) and M.S. (1979) and Ph.D. (1981) in Materials Science and Engineering, all from the University of Florida. From 1981-1982, he was a Fulbright Post-Doctoral Fellow at the University of Western Australia in the Department of Soil Science and Plant Nutrition and the Royal Perth Hospital where he studied the biophysical chemistry origin of pathological biomineralization including human kidney stone disease. Dr. Adair was a Principal Research Scientist at Battelle Memorial Institute from 1982-1986. He joined Penn State as a Research Associate at the Materials Research Lab from 1986-1990. Adair was a faculty member from 1990 to 1997 at the University of Florida. He has been at Penn State as a Professor of Materials Science and Engineering since 1998. In 2012, he received courtesy faculty appointments in Biomedical Engineering and Pharmacology. He co-founded PendreaBio (formerly Keystone Nano, Inc.) in 2005 and serves as a member of the Board of Directors and Chief Science Officer. Dr. Adair is the author or co-author of over 250 publications, nineteen US patents with numerous other foreign patents, many technical reports to sponsoring agencies, and several copyrights on computer software. He has been chair or co-chair of many symposia related to materials chemistry and colloid and powder processing science at American Ceramic Society and American Chemical Society at national and international meetings. He is also the co-editor of twelve books including the Handbook of Characterization Techniques for the Solid-Solution Interface.
Director Institute of Biomed Eng. & Nano-med, Taiwan
Dr. Feng-Huei Lin was born in 1957 in Taiwan. He obtained his BS degree in Department of Earth Sciences, National Cheng Kung University (NCKU), Taiwan, in 1980. In early 1990, Dr. Lin was recruited as an associate professor in Centre for Biomedical Engineering, College of Medicine, National Taiwan University (NTU); where he started his academic career. In 1997, he was promoted to the full professor. He organized to setup the Institute of Biomedical Engineering in NTU and served as acting director in the institute (1997-1999). Afterwards, Dr. Lin was invited to be the first director in Department of Biomedical Engineering of NTU-hospital with engineering background (2003-2005). Then he returned to Institute of Biomedical Engineering, NTU, as director (2005-2008). Assigned by National Science Council, Taiwan Dr. Lin made the budget allocation and future 10-year financial plan as the Convenor of Biomedical Division (2006-2009). Then Dr. Lin transferred to Division of Biomedical Engineering, National Health Research Institutes (NHRI), as the director and took charge of the development of biomaterials and tissue engineering (2008-2012). Now, he is the distinguished professor in NTU, chair professor in National Taipei University of Technology, executive editor of Journal of Biomedical Engineering, International fellow of International College of Biomaterials Sciences and Engineering, Fellow, The American Institute for Medical and Biological Engineering (AIMBE). Dr Lin has served as standing committee members in many international societies since 1996. He was the permanent international advisory board in Ceramic, Cell and Tissue (CCT) (1998-2010); and served as the President in 2010. He was one of the standing committee members in WACBE (2005-) and council member in TERMIS-AP Chapter (2009-2011). He also served as editorial board members in many SCI journals, e.g. Biomaterials, International Journal of Biomaterials, International Journal of Biomaterial Research and Engineering, Journal of Musculoskeletal Research etc..
School of MedicineUniversity of Crete, Greece
Achilleas Gravanis, Professor of Pharmacology Medical School University of Crete. Researcher Institute of Molecular Biology & Biotechnology FORTH, Affiliated Research Professor Center of Drug Discovery Northeastern University Boston. He served as Member and Chairman of many research committees of the European Union, as member of the Fellowships Committee Federation European Biochemical Societies (FEBS), as chairman of Life Sciences Committee, National Council of Research & Τechnology, as member of the Board of Hellenic Foundation of Research & Innovation. Co-founder of biotechnology spin-offs Bionature Ltd and ReNeuroCell Ltd. Affiliated Principal investigator, Emulate SA, a spinoff of Harvard University. His research group is developing synthetic compounds, agonists of neurotrophin receptors, with neuroprotective and neurogenic properties and potential applications in therapeutics of neurodegenerative diseases. Additionally, his group is focusing on 3D microscaffold bioengineering and neural stem cell technologies to develop neuroimplants for spinal cord injury and neurobiosensors for drug screening.
Leader-Hemp/Flax Textile Research Team, Poland
Assoc. Prof. Dr. Malgorzata Zimniewska works at the Institute of Natural Fibres & Medicinal Plants National Research Institute in Poland. She received her PhD (2006) and habilitation (2016) in material engineering from the Faculty of Material Technologies and Textile Design of Technical University of Łodz. She received a title of Assoc. Prof. of Institute of Natural Fibres & Medicinal Plants in 2011. M. Zimniewska conducts research on bio-based materials development, natural lignocellulosic fiber processing, technologies and evaluation, to meet the specific needs of different fiber applications including pro-healthy textiles and bast fibers textile application to reinforce composites. M. Zimniewska investigates bioactivity of flax and hemp fibers to develop of bio-based functional textiles for specific target. M. Zimniewska is a Member of Advisory Council of BIOEAST Board - Central and Eastern European initiative for knowledge-based Agriculture, Aquaculture and Forestry in the Bioeconomy and a Member of Scientific Council of Working Group on Fibres and Textile, EIHA European Industrial Hemp Association. She works as an expert of BIOEAST Foresight “Sustainable Bioeconomies towards 2050” in Central and Eastern European. She served as Vice Chair of Quality Control for European Commission in frame programme H2020, Research Executive Agency, Future and Emerging Technologies, 2018 – 2019 and in Horizon Europe, European Innovation Council Pathfinder HORIZON-EIC-2021-PATHFINDEROPEN. M. Zimniewska is an expert of European Technology Platform for the Future of Textiles and Clothing. Malgorzata Zimniewska has been principal investigator of many international, European and national projects. She has authored and co-authored more than 170 articles published in research journals, conference proceedings and book chapters. She is a co-author of 6 patents, which were awarded with 4 gold, one silver and one bronze medals at international innovation exhibitions and of President of Polish Chamber of Commerce Award KIG INNOVATICA 2010. She was also awarded with Silver Cross of Merit, 2010.
Director-Bio-Medical Nano/Micro Forming Lab Taiwan
Professor Yung-Kang Shen received his Ph.D. degree from the National Taiwan University, Taipei, Taiwan, in 1995. He has been a Professor of the School of Dental Technology at Taipei Medical University (TMU) since 2014. He has been a Chairman of the School of Dental Technology of TMU since 2018. He is also the Director of Bio-Medical Nano/Micro Forming Lab of TMU, the Researcher of Nano Tissue Engineering and Image Research Center of Taipei Medical University Hospital (TMUH), the Researcher of Sleep Research Center of Taipei Medical University Hospital (TMUH), the Researcher of the Department of Otolaryngology of Taiwan Adventist Hospital (TAH). He is the Chairman of Taiwan Oral Biomedical Engineering Association, Co-Organizing Directors for Asia Pacific Society for Materials Research (APSMR), Co-Organizing Directors for Asia Pacific Society for Biology and Medical Sciences (APSBMS), the Supervisor of SME Taipei Chapter and the Director of Taiwan Society for Abrasive Technology. He is an Adjunct Professor of University Hasanuddin (Indonesia) since 2020. He is a Visiting Professor of Changchun University of Science and Technology (China) since 2012. He is a Part-time Professor of ShanDong University (China) since 2016. He is a Guest Professor of Zhejiang University of Technology (China) since 2017. Professor Shen is a project review committee member of the Ministry of Science and Technology (Taiwan). His research includes metamaterial, scaffold fabrication (PCL/graphene), 3D/4D/5D printing, biomedical nano/micro forming technology, medical bionics design and manufacturing, animal model for medicine therapy. Now, he has published more than 135 journal papers and 120 conference papers. Professor Shen has served as the keynote speaker or invited speaker at more than 28 international seminars. Professor Shen was awarded the Best Paper Award for the 3rd International Forum on Systems and Mechatronics in Singapore in 2010. He was also awarded the First Prize in Poster Presentation Award for the 2nd Research Week-International Symposium 2012 of COM on Dental Technology, Oral Health Care and Biomedical Device in Taipei in 2012. He was also awarded the Most Cited Article Award, 2012 to 2013 for "International Journal of Precision Engineering and Manufacturing" (SCI Journal). Professor Shen currently serves as the Editorial Board for Polymers (SCI Journal), Biology, Engineering and Medicine; Journal of Precision Medicine and Public Health; Open Access Journal of Science and Technology; International Open Access Journal of Translational Medicine and International Journal of Manufacturing Engineering.
University of Sunderland UK
Prof. Amal Ali Elkordy is a Professor of Pharmaceutics at the University of Sunderland, Faculty of Health Sciences and Wellbeing, Sunderland, UK. She has published a significant number of papers on various fields of pharmaceutics, evident from over 130 publications including journal articles, book chapters and conference papers. She has supervised many PhD students to the successful completion and she is currently supervising a number of PhD students. She is a book editor, an editorial board member for some journals in pharmaceutical sciences and a reviewer for several national and international pharmaceutics journals. She presented keynote and invited speeches at different conferences worldwide. She also chair scientific sessions at national and international pharmaceutical conferences. Recently she acted as external examiner for 17 PhD examinations at different universities in the UK and for seven PhD/MPhil theses abroad. She has been the recipient of many awards from different conferences and symposia.
Director Clinical Research at CHDI Foundation, USA
Dr. Anka G. Ehrhardt is a biophysicist with a doctorate degree in human physiology. Throughout her career, Dr. Ehrhardt combined scientific and technical expertise with strategic excellence and operational savvy to build and run laboratories and teams, design, implement, and run clinical studies, drive them to become Centers of Excellence and key partners, serving the discovery and development needs of large biopharmaceutical companies and patient-need-focused organizations. Through her work at Merck & Co., Inc. and Bristol Myers Squibb, Dr. Ehrhardt encountered the key issues in biopharma research and development; and demonstrated the power and success of strategic planning and analysis. Based on observed needs, Dr. Ehrhardt built and lead teams of increasing size in developing and implementing strategies, contributing to the discovery and development of over 50 key leads and drugs. In 2017, Dr. Ehrhardt joined CHDI Management, Inc., where she is directing international clinical studies and clinical biomarker research. Dr. Ehrhardt is currently on the board of different industry organizations, fostering innovation and collaboration between industry, academia, and government organizations.
North Carolina State University USA
Professor of Chemistry at North Carolina State University. He has also served as a Finland Distinguished Professor of Chemistry with the department of Chemstry of the University of Helsinki, Finland and Distinguished visiting Professor with the centre for Advanced Materials and the Department of Chemistry King Abdulaziz University, Jedah, Saudi Arabia. Professor Argyropoulos’s research team is internationally recognized for his leading contributions to Green Chemistry using cellulose and lignin wood-based polymers. His work focuses at promoting our understanding of the structure and reactivity of such polymers and the development of novel NMR and material science techniques for the structural elucidation and upgrading of these biopolymers. The efforts of his research group have been disseminated in excess of 200 scientific papers, numerous scientific conferences invited presentations and patents. Professor Argyropoulos is a fellow of the Royal Society of Chemistry, International Academy of Wood science and the Chemical Institute of Canada
University of Bologna Italy
Paola Fabbri is associate professor of Materials Science and Technology at the University of Bologna, in Italy; she is expert in the field of polymeric materials, composites and bioplastics. Her activities primarily concern the selection of plastic materials for specific applications in many industrial sectors, including advanced fields (biomedical, sensors, electronics and more), the development and/or modification of new polymeric materials by combining chemical and technological routes, with the main aim of understanding their structure-properties correlations. She is highly involved in national and international research programs, and actively interacts with Companies and industrial Associations working in the field of plastics and bioplastics (packaging, medical, materials and process development, recycling and more), by acting as scientific advisor and supporting technology transfer.
Director-BioMolecular Engineering Research Center Boston University USA
Dr. Temple Smith obtained his PhD in Nuclear Physics from the University of Colorado in 1969, followed by an NIH (USA) postdoctoral fellowship under the direction of the mathematician, Stanislaw Ulam, and the molecular biologist, John R. Sadler. Dr. Smith is one of the founders of GenBank, initially at Los Alamos National Laboratory, and the co-developer, with Michael Waterman, of the Smith-Waterman sequence alignment algorithm. Beginning in 1988 Dr. Smith organized the “Genes and Machines” conference series in bioinformatics. As director of the Boston University BioMolecular Engineering Research Center, he directed the research of over twenty Post doctoral and grad students. His research focused on protein evolution of: the WD-repeat family; the Life Guard apoptotic regulatory family; the evolutionary of the Drosophila clade, and the origin and evolutionary of the genetic translation system. He is a follow of the American Association for the Advancement of Science (AAAS), and a fellow of the ISCB. He has 200 plus reviewed scientific publications. In 2011 Dr. Smith was elected Emeritus Professor of BioMedical Engineering at Boston University. Dr. Smith is an avid skier, ice climber, sailor, hockey coach and family man. He is also the co-founder of a gene engineering company, Modular Genetics.
National Cheng Kung University Taiwan
After obtaining Ph.D. in Biochemistry in 1993 from the Keck School of Medicine at the University of Southern California, USA. Dr. Lynn L.H. Huang was recruited as a Research Assistant Professor at the Center for Biomedical Engineering in the College of Medicine, National Taiwan University, Taiwan. She then served as an Associate Professor in the Institute of Biotechnology at the National Cheng Kung University and was promoted to a full Professorship in 1999. She is now a Distinguished Professor in the Department of Biotechnology & Bioindustry Sciences and co-appointed in the Institute of Clinical Medicine and Department of Food Safety / Hygiene and Risk Management in the College of Medicine at the National Cheng Kung University in Taiwan. Since 2008, she was elected as a fellow of Biomaterials Science and Engineering (FBSE) because of her pioneering contributions in collagen-hyaluronan biomaterials and leadership in regenerative medicine education. Except numerous research awards and innovation awards, she was awarded Life time Achievement Inventor in 2014. She served as a Taiwan delegate in the International Union of Societies for Biomaterials and Engineering during 2000~2018. She is now an editorial honorary advisory board member for the “Journal of Biomaterials and Tissue Engineering”. She has been working in the fields of extracellular matrix biochemistry and biomaterials for over 37 years and was the first person proposed a non-contractible collagen-hyaluronan scaffold in the world. Her expertise is in biochemistry of collagen and hyaluronan, biomaterials, tissue engineering, stem cell biology, 3-dimensional culture, biocompatibility, wound healing, animal models, etc. Her lab has successfully proved plasticity of mesenchymal stem cells by extracellular microenvironment and developed a hydrogel therapy to overcome keloid scar, an inherited disease. Recently, with a strict non-regenerative hind limb ischemia model in diabetic mice, she has invented a novel regenerative medicine for the ischemic treatment to prevent limb amputation. She now has over 84 international approved patents and has co-authored over 210 articles published in peer-reviewed scientific journals, conference proceedings, and book chapters.
Imperial College UK
Alessandra Pinna is an Imperial College research fellow (ICRF) and visiting scientist in Wilkinson’s lab at Crick Institute since 2019. Her long-term research interests involve the development of nanostructured ceramic and hybrid organic-inorganic films, nanoparticles, and nano composites via a sol-gel method for biomedical applications with particular interest in drug delivery and antimicrobial- antioxidant system. Her academic training and research experience have provided her with an excellent background in multiple disciplines including chemistry, biology, and materials science. She has been working in a research lab for more than 10 years. During this time, she was also part of exchange projects at the University Hospital of Zurich, working on neuro degeneration in Bovine Spongiform Encephalopathy, and at CSIRO in Melbourne developing skills working on composite materials based on Metal Organic Frameworks and cerium oxide.
Hiroshima University Japan
Dr. Archana is a periodontist and implantologist who is currently working as an assistant professor in Hiroshima University, Japan. She completed her master’s education from India and moved to Japan as a visiting researcher along with receiving higher clinical training in implantology. After a year of clinical training, she pursued her Ph.D. in Hiroshima University and graduated along with receiving the excellent doctoral candidate award in 2021. She was promptly hired as an assistant professor in the Department of Biomaterials, Hiroshima University, and is currently working on research projects related to periodontal tissue regeneration and peri-implant soft tissue management.
Erasmus University Medical Centre Netherlands
Willem Van Wamel, PhD, is associate professor in the Department of Medical Microbiology and Infectious Diseases Dr Van Wamel earned his doctoral degree in microbiology from the Eijkman Winkler Institute for Microbiology, Infectious Diseases, and Inflammation at the University of Utrecht in Utrecht, The Netherlands; the topic of his doctoral thesis was “Regulation of Virulence Factors in Staphylococci.” In addition, he completed postdoctoral work and research there, as well as at the Laboratory of Bacterial Pathogenesis and Immunology at Rockefeller University in New York, New York, and Dartmouth Medical School in Hanover, New Hampshire.
University of Westminster UK
Dina Ahmed, MSc in pharmacology and current PhD student at the University of Westminster, London, UK. Besides, she is working as a researcher at the Center of Stem Cells and Regenerative Medicine which constitutes a part of Egypt Center for Research and Regenerative Medicine (ECRRM) in Egypt. Her research focus is on implementing materials science in the fields of sustained/tailored drug delivery and skin tissue regeneration. Dina’s MSc project included encapsulating the poly-3-hydroxybutyrate microspheres with the anti-neurodegenerative drug (Cl-amidine) for the first time which provided sustained release and shown to have anti-cancerous effects through suppressing the vascular endothelial growth factor (VEGF) expression (published in mdpi- Dina’s PhD project involves applying 3D printing of polymeric patches which aim at promoting wound healing and skin tissue regeneration in case of burns and diabetic wounds.
Ecole Normale Supérieure-PSL Research University France
Carole Aimé is a CNRS researcher working at the Chemistry Department of the Ecole Normale Supérieure in Paris-France. After a PhD in Bordeaux University-France, on self-assembling amphiphilic systems, she joined Kyushu University-Japan, where she designed functional coordination nanoparticles from nucleotides and lanthanide ions. She got a CNRS position working on the engineering of biomaterials and bionanocomposites combining inorganic nanoparticles with collagen at the Laboratoire de Chimie de la Matière Condensée de Paris-Sorbonne University-France. She moved to ENS in 2018 to develop integrative in vitro models for biological and biomedical research.
Charite University Germany
Lorraine Braga Ferreira is a researcher, associate at the Department of Dentistry at the Charite University in Berlin, developed the project with regenerative bone and dental biomaterials, using magnesium and simvastatin, which was the subject of her doctorate and postgraduate studies in Brazil, at the University of Sao Paulo. She is a member of the research and study group on stem cells at the Federal University of Uberlandia- Brazil.
School of Mechanical Engineering Korea University Korea
Jin-A Kim is a research professor in the School of Mechanical Engineering at Korea University. She received her Ph.D. degree in stem cell-based regenerative medicine. Her research interests include organoid-based disease modeling and therapeutic target development, especially for cancer and neurodegenerative diseases.
The Hong Kong Polytechnic University Hong Kong
Ahmed M. Saleque received BSc. in Electrical & Electronic Engineering and MEngg in Telecommunications from American International University-Bangladesh (AIUB) in 2010 and 2012 respectively. In 2015, he received joint Erasmus Mundus MSc degree from University of Nottingham, University of Oviedo, and University of Rome and also a visiting scholar at the WEMPEC laboratory, University of Wisconsin Madison, USA. He was an Assistant Professor at AIUB. In 2019, he was awarded the Hong Kong Ph.D. fellowship and currently pursuing Ph.D. in Applied Physics from The Hong Kong Polytechnic University. His research interests include Interfacial Steam Generation, Perovskite solar cell and biosensors.
Silesian Medical University Poland
Dr. Jarosław Paluch was born in 1961. He was graduated in Silesian Medical University in 1986. He has completed his specialization- ENT in 1998 and Medical doctor degree in 2003. Currently he is working as a lecturer in ENT Clinic of Silesian Medical University in Katowice. The range of scientific activity: 1) Cancer biology 2) Electron microscopy (SEM, TEM), atomic force microscopy and near tome spectroscopy (MALDI-TOF, SIM-TOF, Raman Spectroscopy)-in medicine and biology. 3) Synchrotron beam used in biological and medical researches 4) Design of novel biomaterials for medical diagnostic procedures and their applications (co-author of some European Patent and Patent Applications)
Brunel University UK
Eyyüp Murat KARAKURT, born in 1988, is doctoral research assistant at Department of Mechanical and Aerospace Engineering, Engineering Faculty, Brunel University London, The UK. He received MSc from Adiyaman University, Adiyaman, Turkey in 2017. His main interests are boronizing, friction welding and porous Ti-based alloys as biomaterial.